The role of chemotherapy in advanced oral cavity cancer;El papel de la quimioterapia en el cáncer de la cavidad oral avanzado

Acta Otorrinolaringologica Espanola

Volumn 60, Issue 4, 2009, Pages 260-267

  Caballero, Miguel ^a   Grau, Juan J ^a   Casellas, Sandra ^a   Bernal Sprekelsen, Manuel ^a   Blanch, José L ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Chemotherapy; Head and neck cancer; Oral cavity; Survival

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; EXPECTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH TUMOR; ORAL SURGERY; OVERALL SURVIVAL; PALLIATIVE THERAPY; PROGNOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; BLEOMYCIN; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MOUTH NEOPLASMS; NEOPLASM STAGING;

EID: 67649494275     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otorri.2009.01.005     Document Type: Article

References (21)

1. Kessler P., Grabenbauer G., Leer A., Bloch-Birkholz A., Vairaktaris E., and Neukam F.W. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46 (2008) 1-5
2. Vokes E.E., Weichselbaum R.R., Lippman S.M., and Hong W.K. Head and neck cancer. N Engl J Med 328 (1993) 184-194
3. Zorat P.L., Paccagnella A., Cavaniglia G., Loreggian L., Gava A., Mione C.A., et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J Nat Cancer Inst 96 (2004) 1714-1717
4. Hitt R., Grau J., Lopez-Pousa A., Berrocal A., Sastre J., Belon J., et al. Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC). J Clin Oncol 23 (2005) 519S
5. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
6. Jacobs C., Lyman G., Vélez-García E., Sridhar K.S., Knight W., Hochster H., et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10 (1992) 257-263
7. Forastiere A.A., Metch B., Schuller D.E., Ensley J.F., Hutchins L.F., Triozzi P., et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10 (1992) 1245-1251
8. Clavel M., Vermorken J.B., Cognetti F., Cappelaere P., Demulder P.H.M., Schornagel J.H., et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (Cabo) versus cisplatin and 5-fluorouracil (Cf) versus cisplatin (C) in recurrent or metastatic squamous-cell carcinoma of the head and neck. A phase III Study of the EORTC Head and Neck-Cancer Cooperative Group. Ann Oncol 5 (1994) 521-526
9. Andreadis C., Vahtsevanos K., Sidiras T., Thomaidis I., Antoniadis K., and Mouratidou D. 5-Fluorouracil and cisplatin in the treatment of advanced oral cancer. Oral Oncol 39 (2003) 380-385
10. Lindskog M., Spenger C., Jarvet J., Graslund A., and Kogner P. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma. J Natl Cancer Inst 96 (2004) 1457-1466
11. Gibson M.K., Li Y., Murphy B., Hussain M.H.A., DeConti R.C., Ensley J., et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group. J Clin Oncol 23 (2005) 3562-3567
12. Grau J.J., Domingo J., Blanch J.L., Verger E., Castro V., Nadal A., et al. Multidisciplinary approach in advanced cancer of the oral cavity: Outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study. Oncology 63 (2002) 338-345
13. Zidan J., Kuten A., Rosenblatt E., and Robinson E. Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer. Oral Oncol 33 (1997) 129-135
14. Grau J.J., Estape J., Blanch J.L., Vilalta A., Castro V., Biete A., et al. Neoadjuvant and adjuvant chemotherapy in the multidisciplinary treatment of oral cancer stage III or IV. Eur J Cancer B Oral Oncol 32B (1996) 238-241
15. Grau J.J. Induction chemotherapy prior to surgery did not improve survival, but may reduce mandibulectomy over surgery alone in locally advanced squamous cell cancer of the oral cavity. Cancer Treat Rev 29 (2003) 341-344
16. Kohno N., Ikari T., Kawaida M., Tanaka K., Kawaura M., Kano S., et al. Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol 30 (2000) 253-258
17. Turner S.L., Kalnins I., Gebski V., and Tiver K.W. Locally advanced (stage III and IV) head and neck cancer: Westmead Hospital experience. Aust N Z J Surg 61 (1991) 744-752
18. Hill B.T., and Price L.A. Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate. Am J Clin Oncol 17 (1994) 1-5
19. Dimery I.W., and Hong W.K. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85 (1993) 95-111
20. Budach V., Stuschke M., Budach W., Baumann M., Geismar D., Grabenbauer G., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 (2005) 1125-1135
21. Garden A.S., Harris J., Vokes E.E., Forastiere A.A., Ridge J.A., Jones C., et al. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22 (2004) 2856-2864